Software - Application
Compare Stocks
5 / 10Stock Comparison
FIG vs ADBE vs CXM vs CNVS vs DSGN
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Application
Entertainment
Biotechnology
FIG vs ADBE vs CXM vs CNVS vs DSGN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Infrastructure | Software - Application | Entertainment | Biotechnology |
| Market Cap | $6.52B | $99.46B | $1.24B | $50M | $986M |
| Revenue (TTM) | $1.06B | $24.45B | $857M | $55M | $0.00 |
| Net Income (TTM) | $-1.31B | $7.21B | $23M | $-9M | $-70M |
| Gross Margin | 82.4% | 89.2% | 67.4% | 53.9% | — |
| Operating Margin | -122.2% | 36.8% | 4.7% | -12.5% | — |
| Forward P/E | 81.1x | 10.2x | 11.2x | 16.1x | — |
| Total Debt | $58M | $6.65B | $47M | $462K | $645K |
| Cash & Equiv. | $403M | $5.43B | $163M | $14M | $17M |
FIG vs ADBE vs CXM vs CNVS vs DSGN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| Adobe Inc. (ADBE) | 100 | 41.1 | -58.9% |
| Sprinklr, Inc. (CXM) | 100 | 24.6 | -75.4% |
| Cineverse Corp. (CNVS) | 100 | 10.0 | -90.0% |
| Design Therapeutics… (DSGN) | 100 | 79.4 | -20.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FIG vs ADBE vs CXM vs CNVS vs DSGN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FIG lags the leaders in this set but could rank higher in a more targeted comparison.
ADBE carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 151.0% 10Y total return vs DSGN's -61.9%
- Better valuation composite
- 29.5% margin vs FIG's -124.5%
- Beta 0.70 vs FIG's 1.55
CXM is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 1 yrs, beta 0.74
- Beta 0.74, current ratio 1.60x
CNVS is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 59.1%, EPS growth 109.0%, 3Y rev CAGR 11.7%
- 59.1% revenue growth vs DSGN's -24.6%
DSGN ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 1.49, Low D/E 0.3%, current ratio 17.14x
- +336.2% vs FIG's -83.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.1% revenue growth vs DSGN's -24.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 29.5% margin vs FIG's -124.5% | |
| Stability / Safety | Beta 0.70 vs FIG's 1.55 | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +336.2% vs FIG's -83.3% | |
| Efficiency (ROA) | 24.8% ROA vs FIG's -56.0%, ROIC 51.4% vs -95.3% |
FIG vs ADBE vs CXM vs CNVS vs DSGN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
FIG vs ADBE vs CXM vs CNVS vs DSGN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ADBE leads in 2 of 6 categories
CNVS leads 1 • DSGN leads 1 • CXM leads 1 • FIG leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ADBE leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ADBE and DSGN operate at a comparable scale, with $24.5B and $0 in trailing revenue. ADBE is the more profitable business, keeping 29.5% of every revenue dollar as net income compared to FIG's -124.5%. On growth, ADBE holds the edge at +12.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $24.5B | $857M | $55M | $0 |
| EBITDAEarnings before interest/tax | -$1.3B | $9.6B | $48M | -$2M | -$78M |
| Net IncomeAfter-tax profit | -$1.3B | $7.2B | $23M | -$9M | -$70M |
| Free Cash FlowCash after capex | $243M | $10.3B | $155M | -$13M | -$54M |
| Gross MarginGross profit ÷ Revenue | +82.4% | +89.2% | +67.4% | +53.9% | — |
| Operating MarginEBIT ÷ Revenue | -122.2% | +36.8% | +4.7% | -12.5% | — |
| Net MarginNet income ÷ Revenue | -124.5% | +29.5% | +2.7% | -16.7% | — |
| FCF MarginFCF ÷ Revenue | +23.1% | +42.2% | +18.1% | -22.8% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +12.0% | +8.9% | -60.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | +11.4% | -90.1% | -113.2% | +6.5% |
Valuation Metrics
CNVS leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 14.4x trailing earnings, ADBE trades at a 74% valuation discount to CXM's 56.2x P/E. On an enterprise value basis, CNVS's 3.1x EV/EBITDA is more attractive than CXM's 28.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6.5B | $99.5B | $1.2B | $50M | $986M |
| Enterprise ValueMkt cap + debt − cash | $6.2B | $100.7B | $1.1B | $37M | $970M |
| Trailing P/EPrice ÷ TTM EPS | -5.21x | 14.42x | 56.22x | 16.06x | -12.94x |
| Forward P/EPrice ÷ next-FY EPS est. | 81.12x | 10.23x | 11.15x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | 1.59x | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 10.57x | 28.02x | 3.14x | — |
| Price / SalesMarket cap ÷ Revenue | 6.17x | 4.18x | 1.45x | 0.64x | — |
| Price / BookPrice ÷ Book value/share | 4.31x | 8.85x | 2.20x | 1.21x | 4.26x |
| Price / FCFMarket cap ÷ FCF | 26.46x | 10.10x | 7.88x | 3.10x | — |
Profitability & Efficiency
ADBE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ADBE delivers a 62.3% return on equity — every $100 of shareholder capital generates $62 in annual profit, vs $-87 for FIG. DSGN carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to ADBE's 0.57x. On the Piotroski fundamental quality scale (0–9), CNVS scores 7/9 vs DSGN's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -87.0% | +62.3% | +3.9% | -24.4% | -33.1% |
| ROA (TTM)Return on assets | -56.0% | +24.8% | +2.0% | -13.4% | -31.3% |
| ROICReturn on invested capital | -95.3% | +51.4% | +6.1% | +20.3% | -28.5% |
| ROCEReturn on capital employed | -4.8% | +44.6% | +6.1% | +22.3% | -34.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 6 | 7 | 2 |
| Debt / EquityFinancial leverage | 0.04x | 0.57x | 0.08x | 0.01x | 0.00x |
| Net DebtTotal debt minus cash | -$345M | $1.2B | -$116M | -$13M | -$16M |
| Cash & Equiv.Liquid assets | $403M | $5.4B | $163M | $14M | $17M |
| Total DebtShort + long-term debt | $58M | $6.6B | $47M | $462,000 | $645,000 |
| Interest CoverageEBIT ÷ Interest expense | — | 66.23x | — | -4.16x | — |
Total Returns (Dividends Reinvested)
DSGN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DSGN five years ago would be worth $6,517 today (with dividends reinvested), compared to $1,045 for CNVS. Over the past 12 months, DSGN leads with a +336.2% total return vs FIG's -83.3%. The 3-year compound annual growth rate (CAGR) favors DSGN at 33.5% vs FIG's -44.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -48.6% | -27.7% | -30.9% | +22.4% | +73.5% |
| 1-Year ReturnPast 12 months | -83.3% | -39.2% | -39.8% | -12.6% | +336.2% |
| 3-Year ReturnCumulative with dividends | -83.3% | -28.2% | -56.0% | -57.2% | +137.8% |
| 5-Year ReturnCumulative with dividends | -83.3% | -49.0% | -71.3% | -89.6% | -34.8% |
| 10-Year ReturnCumulative with dividends | -83.3% | +151.0% | -71.3% | -91.7% | -61.9% |
| CAGR (3Y)Annualised 3-year return | -44.9% | -10.5% | -23.9% | -24.6% | +33.5% |
Risk & Volatility
Evenly matched — ADBE and DSGN each lead in 1 of 2 comparable metrics.
Risk & Volatility
ADBE is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than FIG's 1.55 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DSGN currently trades 91.5% from its 52-week high vs FIG's 13.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.55x | 0.70x | 0.74x | 1.46x | 1.49x |
| 52-Week HighHighest price in past year | $142.92 | $422.95 | $9.40 | $7.39 | $17.25 |
| 52-Week LowLowest price in past year | $16.60 | $224.18 | $4.71 | $1.77 | $3.11 |
| % of 52W HighCurrent price vs 52-week peak | +13.5% | +56.9% | +53.8% | +34.8% | +91.5% |
| RSI (14)Momentum oscillator 0–100 | 51.1 | 48.3 | 45.1 | 53.5 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 14.1M | 5.4M | 3.5M | 140K | 399K |
Analyst Outlook
CXM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: FIG as "Hold", ADBE as "Buy", CXM as "Hold", DSGN as "Buy". Consensus price targets imply 87.1% upside for FIG (target: $36) vs 10.8% for DSGN (target: $18).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | — | Buy |
| Price TargetConsensus 12-month target | $36.17 | $345.50 | $7.13 | — | $17.50 |
| # AnalystsCovering analysts | 7 | 62 | 17 | — | 7 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | 1 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +11.3% | +0.4% | +0.4% | 0.0% |
ADBE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNVS leads in 1 (Valuation Metrics). 1 tied.
FIG vs ADBE vs CXM vs CNVS vs DSGN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FIG or ADBE or CXM or CNVS or DSGN a better buy right now?
For growth investors, Cineverse Corp.
(CNVS) is the stronger pick with 59. 1% revenue growth year-over-year, versus 7. 6% for Sprinklr, Inc. (CXM). Adobe Inc. (ADBE) offers the better valuation at 14. 4x trailing P/E (10. 2x forward), making it the more compelling value choice. Analysts rate Adobe Inc. (ADBE) a "Buy" — based on 62 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FIG or ADBE or CXM or CNVS or DSGN?
On trailing P/E, Adobe Inc.
(ADBE) is the cheapest at 14. 4x versus Sprinklr, Inc. at 56. 2x. On forward P/E, Adobe Inc. is actually cheaper at 10. 2x.
03Which is the better long-term investment — FIG or ADBE or CXM or CNVS or DSGN?
Over the past 5 years, Design Therapeutics, Inc.
(DSGN) delivered a total return of -34. 8%, compared to -89. 6% for Cineverse Corp. (CNVS). Over 10 years, the gap is even starker: ADBE returned +151. 0% versus CNVS's -91. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FIG or ADBE or CXM or CNVS or DSGN?
By beta (market sensitivity over 5 years), Adobe Inc.
(ADBE) is the lower-risk stock at 0. 70β versus Figma, Inc. 's 1. 55β — meaning FIG is approximately 121% more volatile than ADBE relative to the S&P 500. On balance sheet safety, Design Therapeutics, Inc. (DSGN) carries a lower debt/equity ratio of 0% versus 57% for Adobe Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FIG or ADBE or CXM or CNVS or DSGN?
By revenue growth (latest reported year), Cineverse Corp.
(CNVS) is pulling ahead at 59. 1% versus 7. 6% for Sprinklr, Inc. (CXM). On earnings-per-share growth, the picture is similar: Cineverse Corp. grew EPS 109. 0% year-over-year, compared to -79. 5% for Sprinklr, Inc.. Over a 3-year CAGR, CNVS leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FIG or ADBE or CXM or CNVS or DSGN?
Adobe Inc.
(ADBE) is the more profitable company, earning 30. 0% net margin versus -118. 4% for Figma, Inc. — meaning it keeps 30. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADBE leads at 36. 6% versus -122. 2% for FIG. At the gross margin level — before operating expenses — ADBE leads at 88. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FIG or ADBE or CXM or CNVS or DSGN more undervalued right now?
On forward earnings alone, Adobe Inc.
(ADBE) trades at 10. 2x forward P/E versus 81. 1x for Figma, Inc. — 70. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FIG: 87. 1% to $36. 17.
08Which pays a better dividend — FIG or ADBE or CXM or CNVS or DSGN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is FIG or ADBE or CXM or CNVS or DSGN better for a retirement portfolio?
For long-horizon retirement investors, Adobe Inc.
(ADBE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), +151. 0% 10Y return). Figma, Inc. (FIG) carries a higher beta of 1. 55 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ADBE: +151. 0%, FIG: -83. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FIG and ADBE and CXM and CNVS and DSGN?
These companies operate in different sectors (FIG (Technology) and ADBE (Technology) and CXM (Technology) and CNVS (Communication Services) and DSGN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FIG is a small-cap high-growth stock; ADBE is a mid-cap deep-value stock; CXM is a small-cap quality compounder stock; CNVS is a small-cap high-growth stock; DSGN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.